$2.47T
Total marketcap
$201.59B
Total volume
BTC 50.21%     ETH 15.64%
Dominance

Xenon Pharmaceuticals XENE Stock

42.89 USD {{ price }} -2.434030% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
3.24B USD
LOW - HIGH [24H]
42.82 - 44.37 USD
VOLUME [24H]
328.56K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.73 USD

Xenon Pharmaceuticals Price Chart

Xenon Pharmaceuticals XENE Financial and Trading Overview

Xenon Pharmaceuticals stock price 42.89 USD
Previous Close 42.61 USD
Open 42.54 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 40.98 - 42.75 USD
52 Week Range 28.79 - 43.75 USD
Volume 625.04K USD
Avg. Volume 395.9K USD
Market Cap 2.67B USD
Beta (5Y Monthly) 1.424295
PE Ratio (TTM) N/A
EPS (TTM) -2.73 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 52.31 USD

XENE Valuation Measures

Enterprise Value 2.19B USD
Trailing P/E N/A
Forward P/E -13.134375
PEG Ratio (5 yr expected) -0.27
Price/Sales (ttm) 3999.2864
Price/Book (mrq) 3.8612769
Enterprise Value/Revenue 3282.895
Enterprise Value/EBITDA -13.773

Trading Information

Xenon Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.424295
52-Week Change 37.89%
S&P500 52-Week Change 20.43%
52 Week High 43.75 USD
52 Week Low 28.79 USD
50-Day Moving Average 39.82 USD
200-Day Moving Average 37.56 USD

XENE Share Statistics

Avg. Volume (3 month) 395.9K USD
Avg. Daily Volume (10-Days) 445.38K USD
Shares Outstanding 63.56M
Float 58.41M
Short Ratio 7.84
% Held by Insiders 0.82%
% Held by Institutions 99.23%
Shares Short 2.92M
Short % of Float 4.62%
Short % of Shares Outstanding 4.59%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -24075.59%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -15.73%
Return on Equity (ttm) -23.99%

Income Statement

Revenue (ttm) 668K USD
Revenue Per Share (ttm) 0.01 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -96333000 USD
EBITDA -159223008 USD
Net Income Avi to Common (ttm) -147430000 USD
Diluted EPS (ttm) -2.31
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 527.04M USD
Total Cash Per Share (mrq) 8.29 USD
Total Debt (mrq) 11.63M USD
Total Debt/Equity (mrq) 1.69 USD
Current Ratio (mrq) 23.714
Book Value Per Share (mrq) 10.885

Cash Flow Statement

Operating Cash Flow (ttm) -114413000 USD
Levered Free Cash Flow (ttm) -66362624 USD

Profile of Xenon Pharmaceuticals

Country United States
State BC
City Burnaby
Address 3650 Gilmore Way
ZIP V5G 4W8
Phone 604 484 3300
Website https://www.xenon-pharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 203

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.

Q&A For Xenon Pharmaceuticals Stock

What is a current XENE stock price?

Xenon Pharmaceuticals XENE stock price today per share is 42.89 USD.

How to purchase Xenon Pharmaceuticals stock?

You can buy XENE shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Xenon Pharmaceuticals?

The stock symbol or ticker of Xenon Pharmaceuticals is XENE.

Which industry does the Xenon Pharmaceuticals company belong to?

The Xenon Pharmaceuticals industry is Biotechnology.

How many shares does Xenon Pharmaceuticals have in circulation?

The max supply of Xenon Pharmaceuticals shares is 75.43M.

What is Xenon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Xenon Pharmaceuticals PE Ratio is now.

What was Xenon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Xenon Pharmaceuticals EPS is -2.73 USD over the trailing 12 months.

Which sector does the Xenon Pharmaceuticals company belong to?

The Xenon Pharmaceuticals sector is Healthcare.

Xenon Pharmaceuticals XENE included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN 1704.47 GBP 2179.91 USD
0
1704.47 GBP 2179.91 USD 1704.47 GBP 2179.91 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD